These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 8365305

  • 21. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases.
    Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, Van der Voort E.
    Intensive Care Med; 1992; 18(4):202-5. PubMed ID: 1430582
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL, Downey GP.
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [Abstract] [Full Text] [Related]

  • 24. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
    St Peter SD, Little DC, Calkins CM, Holcomb GW, Snyder CL, Ostlie DJ.
    J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
    [Abstract] [Full Text] [Related]

  • 25. [Use of antithrombin III concentrates].
    Vinazzer H.
    Beitr Infusionsther; 1989 Apr; 24():151-8. PubMed ID: 2481532
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
    Emerson TE, Fournel MA, Redens TB, Taylor FB.
    Am J Med; 1989 Sep 11; 87(3B):27S-33S. PubMed ID: 2679067
    [Abstract] [Full Text] [Related]

  • 27. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M, Minematsu Y, Fujii J, Mori K, Minato T, Miyagawa S, Fujimura R, Morikage N, Arata Y, Nakano C, Wada A, Ito T.
    Ther Apher Dial; 2013 Oct 11; 17(5):472-6. PubMed ID: 24107274
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C, Wuillemin WA, Zeerleder S.
    Blood Coagul Fibrinolysis; 2006 Sep 11; 17(6):445-51. PubMed ID: 16905947
    [Abstract] [Full Text] [Related]

  • 30. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A.
    BMJ Open; 2016 Dec 30; 6(12):e012850. PubMed ID: 28039291
    [Abstract] [Full Text] [Related]

  • 31. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec 30; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 32. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C, Páramo JA, Rocha E.
    Sangre (Barc); 1992 Feb 30; 37(1):5-10. PubMed ID: 1585238
    [Abstract] [Full Text] [Related]

  • 33. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
    Kessler CM, Tang Z, Jacobs HM, Szymanski LM.
    Blood; 1997 Jun 15; 89(12):4393-401. PubMed ID: 9192763
    [Abstract] [Full Text] [Related]

  • 34. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS, Bauer KA, Rosenberg RD, Kavanaugh EJ, Davies DC, Bogdanoff DA.
    Am J Med; 1989 Sep 11; 87(3B):53S-60S. PubMed ID: 2679072
    [Abstract] [Full Text] [Related]

  • 35. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
    Emerson TE, Fournel MA, Leach WJ, Redens TB.
    Circ Shock; 1987 Sep 11; 21(1):1-13. PubMed ID: 3545529
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
    Mertens R, Peschgens T, Granzen B, Heimann G.
    Klin Padiatr; 1999 Sep 11; 211(2):65-9. PubMed ID: 10407813
    [Abstract] [Full Text] [Related]

  • 37. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M, Toh CH, Thachil J, Watson HG.
    Br J Haematol; 2009 Apr 11; 145(1):24-33. PubMed ID: 19222477
    [Abstract] [Full Text] [Related]

  • 38. First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation.
    Stiel L, Mayeur-Rousse C, Helms J, Meziani F, Mauvieux L.
    Thromb Res; 2019 Nov 11; 183():153-158. PubMed ID: 31678710
    [Abstract] [Full Text] [Related]

  • 39. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG, Hvas CL, Tønnesen E, Hvas AM.
    Acta Anaesthesiol Scand; 2014 May 11; 58(5):525-33. PubMed ID: 24580049
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T, Saitoh D, Wada H, Asakura H.
    Crit Care; 2014 Sep 15; 18(5):497. PubMed ID: 25220851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.